The cell membrane plays a central role in the fitness and performance of microbial factories therefore it is an attractive engineering target. goal this work to develop systematic framework for identifying features use as targets. metrics that describe composition can be visualized “knobs” modulate various “outcomes”, such physical properties metabolic activity form growth productivity, with th...

BackgroundSodium-glucose cotransporter 2 (SGLT-2) inhibitors are currently used to treat patients with diabetes. Previous studies have demonstrated that treatment SGLT-2 is accompanied by altered metabolic phenotypes. However, it has not been investigated whether the hypothalamic circuit participates in development of compensatory phenotypes triggered inhibitors. MethodsMice were fed a standard...

The increasing number of patients with fatty liver disease is a major health problem. Fatty metabolic dysfunction has been recognized as nonalcoholic (NAFLD). Although there no standard therapy for NAFLD, previous reports support the effect sodium-glucose cotransporter 2 (SGLT2) inhibitors on NAFLD. Recently, was proposed to be defined novel concept, “metabolic associated (MAFLD)”, and it that ...

One of the most fundamental molecular processes in response to hypoxia is activation and stabilization a transcriptional factor called induced 1a (HIF-1a), which responsible for regulation many downstream effector genes. Multiple key biological pathways such as proliferation, energy metabolism, invasion, metastasis are governed by these This article discusses role hypoxia-inducible (HIF-1a) met...

In the tumor immune microenvironment, CD8+ T cells differentiate towards functional failure. The exhaustion of (Tex) showed varying degrees effect dysfunction, loss proliferation ability, and sustained high expression a variety inhibitory receptors, with metabolic epigenetic changes. Tex are heterogeneous, including several subsets different characteristics at stages differentiation. Immune che...

BACKGROUND/AIMS Angiotensin converting enzyme 2 (ACE2) is highly expressed in the kidney and recognized to be renoprotective by degrading Angiotensin II to Angiotensin (1-7) in diabetic nephropathy. However, little is known about the role of urinary ACE2 (UACE2) in diabetes. The present study was performed to evaluate UACE2 levels in type 2 diabetic patients with various degrees of albuminuria ...

The use of protease inhibitors and non-nucleoside reverse transcriptase inhibitors for the treatment of HIV infection and AIDS has been associated with multiple abnormalities in glucose and lipid metabolism. Specifically, these abnormalities include insulin resistance, increased triglycerides and increased LDL cholesterol levels. The metabolic disturbances are due to a combination of factors, i...

Little is known about of the comparative cardiac lusitropic and coronary vasoactive effects of type III phosphodiesterase inhibitors independent of their systemic circulatory effects. We hypothesized that phosphodiesterase inhibitors have dissimilar concentration-dependent effects on cardiac function and metabolism and that their coronary vasodilatory effects are solely dependent on flow autore...

Diabetes mellitus has been demonstrated to be closely associated with osteoporosis. Accordingly, hypoglycemic therapy is considered effective in treating metabolic bone disease. Recently, the effects of dipeptidyl peptidase-4 (DPP-4) inhibitors, a new type of antidiabetic drug, on bone metabolism have been widely studied. This review mainly describes the effects of DPP-4 inhibitors on bone meta...

The influence of metabolic inhibitors and low temperatures upon D-xylose transfer has been studied in rat diaphragm muscle preparations in vitro. Using intact fiber preparations, it has been confirmed that at body temperature metabolic inhibitors like DNP have an insulin-like action in that they permit D-xylose to distribute into previously unavailable intracellular aqueous regions; inhibitors,...